Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities

PeerJ

Volumn 2014, Issue 1, 2014, Pages

  Lu, Jing ^a   Turnbull, Lynne ^a   Burke, Catherine M ^a   Liu, Michael ^a   Carter, Dee A ^b   Schlothauer, Ralf C ^c   Whitchurch, Cynthia B ^a   Harry, Elizabeth J ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Chief Technology Officer   (New Zealand)

Author keywords

Antibacterial; Biofilm; Honey; Methylglyoxal; Staphylococcus aureus; Wounds

Indexed keywords

HYDROGEN PEROXIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BIOFILM; CELL VIABILITY; CHRONIC WOUND; CONFOCAL LASER MICROSCOPY; HONEY; MANUKA HONEY; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS; WOUND HEALING;

EID: 84897929442     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.326     Document Type: Article

References (48)

1. Adams CJ, Boult CH, Deadman BJ, Farr JM, Grainger MNC, Manley-Harris M, Snow MJ. 2008. Isolation by HPLC and characterisation of the bioactive fraction of New Zealand manuka (Leptospermum scoparium) honey. Carbohydrate Research 343:651-659
2. Al-Waili N, Al Ghamdi A, Ansari MJ, Al-Attar Y, Osman A, SalomK. 2013. Differences in composition of honey samples and their impact on the antimicrobial activities against drug multiresistant bacteria and pathogenic fungi. Archives of Medical Research 44:307-316
3. Al-Waili N, SalomK, Al-Ghamdi AA. 2011. Honey for wound healing, ulcers, and burns; data supporting its use in clinical practice. The Scientific World Journal 11:766-787
4. Alandejani T,Marsan JG, Ferris W, Slinger R, Chan F. 2008. Effectiveness of honey on S. aureus and P. aeruginosa biofilms. Otolaryngology-Head and Neck Surgery 139:P107-P107
5. Allen KL,Molan PC, Reid GM. 1991. A survey of the antibacterial activity of some New Zealand honeys. Journal of Pharmacy and Pharmacology 43:817-822
6. Battin TJ, SloanWT, Kjelleberg S, Daims H, Head IM, Curtis TP, Eberl L. 2007. Microbial landscapes: new paths to biofilm research. Nature Reviews Microbiology 5:76-81
7. Bauer J, Siala W, Tulkens PM, Van Bambeke F. 2013. A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of Daptomycin and Delafloxacin against Staphylococcus aureus biofilms. Antimicrobial Agents and Chemotherapy 57:2726-2737
8. Blair SE, Cokcetin NN, Harry EJ, Carter DA. 2009. The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis. European Journal of Clinical Microbiology and Infectious Diseases 28:1199-1208
9. Braoudaki M, Hilton AC. 2004. Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. Journal of Clinical Microbiology 42:73-78
10. Cars O, Odenholt-Tornqvist I. 1993. The post-antibiotic sub-MIC effect in vitro and in vivo. Journal of Antimicrobial Chemotherapy 31(Suppl D):159-166
11. Chirife J, Herszage L, Joseph A, Kohn ES. 1983. In vitro study of bacterial growth inhibition in concentrated sugar solutions: microbiological basis for the use of sugar in treating infected wounds. Antimicrobial Agents and Chemotherapy 23:766-773
12. Chirife J, Scarmato G, Herszage L. 1982. Scientific basis for use of granulated sugar in treatment of infected wounds. Lancet 1:560-561
13. Colsky AS, Kirsner RS, Kerdel FA. 1998. Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface. Archives of Dermatology 134:1006-1009
14. Cooper R. 2008. Using honey to inhibit wound pathogens. Nursing Times 104(46):48-49.
15. Cooper RA, Jenkins L, Henriques AF, Duggan RS, Burton NF. 2010. Absence of bacterial resistance to medical-grade manuka honey. European Journal of Clinical Microbiology and Infectious Diseases 29:1237-1241
16. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G. 2003. The application of biofilm science to the study and control of chronic bacterial infections. Journal of Clinical Investigation 112:1466-1477
17. Davies J, Spiegelman GB, Yim G. 2006. The world of subinhibitory antibiotic concentrations. Current Opinion in Microbiology 9:445-453
18. Forrest RD. 1982. Early history of wound treatment. Journal of the Royal Society of Medicine 75:198-205.
19. Fux CA, Costerton JW, Stewart PS, Stoodley P. 2005. Survival strategies of infectious biofilms. Trends in Microbiology 13:34-40
20. Gresley AL, Kenny J, Cassar C, Kelly A, Sinclair A, Fielder MD. 2012. The application of high resolution diffusion NMR to the analysis of manuka honey. Food Chemistry 135:2879-2886
21. Haddadin RN, Saleh S, Al-Adham IS, Buultjens TE, Collier PJ. 2010. The effect of subminimal inhibitory concentrations of antibiotics on virulence factors expressed by Staphylococcus aureus biofilms. Journal of Applied Microbiology 108:1281-1291
22. Haddix PL, Jones S, Patel P, Burnham S, Knights K, Powell JN, LaFormA. 2008. Kinetic analysis of growth rate, ATP, and pigmentation suggests an energy-spilling function for the pigment prodigiosin of Serratia marcescens. Journal of Bacteriology 190:7453-7463
23. Hoyle BD, Costerton JW. 1991. Bacterial resistance to antibiotics: the role of biofilms. Progress in Drug Research 37:91-105.
24. Jagani S, Chelikani R, Kim DS. 2009. Effects of phenol and natural phenolic compounds on biofilm formation by Pseudomonas aeruginosa. Biofouling 25:321-324
25. Jervis-Bardy J, Foreman A, Bray S, Tan L,Wormald PJ. 2011. Methylglyoxal-infused honey mimics the anti-Staphylococcus aureus biofilm activity of manuka honey: potential implication in chronic rhinosinusitis. Laryngoscope 121:1104-1107
26. Junker LM, Clardy J. 2007. High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development. Antimicrobial Agents and Chemotherapy 51:3582-3590
27. Kilty SJ, Duval M, Chan FT, Ferris W, Slinger R. 2011. Methylglyoxal: (active agent of manuka honey) in vitro activity against bacterial biofilms. International Forum of Allergy & Rhinology 1:348-350
28. Kwakman PH, Te Velde AA, de Boer L, Vandenbroucke-Grauls CM, Zaat SA. 2011. Two major medicinal honeys have different mechanisms of bactericidal activity. PLoS ONE 6:e17709
29. Kwakman PH, Zaat SA. 2012. Antibacterial components of honey. IUBMB Life 64:48-55
30. Maddocks SE, Jenkins RE, Rowlands RS, Purdy KJ, Cooper RA. 2013. Manuka honey inhibits adhesion and invasion of medically important wound bacteria in vitro. Future Microbiology 8:1523-1536
31. Maddocks SE, Lopez MS, Rowlands RS, Cooper RA. 2012. Manuka honey inhibits the development of Streptococcus pyogenes biofilms and causes reduced expression of two fibronectin binding proteins. Microbiology 158:781-790
32. Majtan J, Bohova J, Horniackova M, Klaudiny J,Majtan V. 2013. Anti-biofilm effects of honey against wound pathogens proteus mirabilis and enterobacter cloacae. Phytotherapy Research 28:69-75
33. Mavric E,Wittmann S, Barth G, Henle T. 2008. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Molecular Nutrition & Food Research 52:483-489
34. McCarty SM, Cochrane CA, Clegg PD, Percival SL. 2012. The role of endogenous and exogenous enzymes in chronic wounds: a focus on the implications of aberrant levels of both host and bacterial proteases in wound healing. Wound Repair and Regeneration 20:125-136
35. Merritt JH, Kadouri DE, O'Toole GA. 2005. Growing and analyzing static biofilms. Current Protocols in Microbiology 22:1B.1.1-1B.1.18. Chapter 1:Unit 1B.1
36. Mirani ZA, Jamil N. 2011. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus. Journal of Basic Microbiology 51:191-195
37. Molan PC. 1999. The role of honey in the management of wounds. Journal of Wound Care 8:415-418.
38. Ngo QD, Vickery K, Deva AK. 2012. The effect of topical negative pressure on wound biofilms using an in vitro wound model. Wound Repair and Regeneration 20:83-90
39. Pankuch GA, Jacobs MR, Appelbaum PC. 1998. Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms. Antimicrobial Agents and Chemotherapy 42:3028-3031.
40. Projan SJ, Youngman PJ. 2002. Antimicrobials: new solutions badly needed. Current Opinion in Microbiology 5:463-465
41. Ranall MV, Butler MS, Blaskovich MA, Cooper MA. 2012. Resolving biofilm infections: current therapy and drug discovery strategies. Current Drug Targets 13:1375-1385
42. Simon A, Traynor K, Santos K, Blaser G, Bode U, Molan P. 2009. Medical honey for wound care-still the 'latest resort'? Evidence-Based Complementary and Alternative Medicine 6:165-173
43. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. 2000. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. Journal of Microbiological Methods 40:175-179
44. Stocks SM. 2004. Mechanism and use of the commercially available viability stain, BacLight. Cytometry Part A 61:189-195
45. Subrt N,Mesak LR, Davies J. 2011. Modulation of virulence gene expression by cell wall active antibiotics in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 66:979-984
46. Weston RJ, Brocklebank LK, Lu Y. 2000. Identification and quantitative levels of antibacterial components of some New Zealand honeys. Food Chemistry 70:427-435
47. Wolcott RD, Rhoads DD, Dowd SE. 2008. Biofilms and chronic wound inflammation. Journal of Wound Care 17:333-341.
48. Zmantar T, Kouidhi B, Miladi H,Mahdouani K, Bakhrouf A. 2010. A microtiter plate assay for Staphylococcus aureus biofilm quantification at various pH levels and hydrogen peroxide supplementation. New Microbiologica 33:137-145.